We are live on ! Find out more
SNTI icon

Senti Biosciences Holdings
SNTI

45 hedge funds and large institutions have $180M invested in Senti Biosciences Holdings in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

7% more funds holding

Funds holding: 42 → 45 (+3)

3% more capital invested

Capital invested by funds: $175M → $180M (+$4.61M)

0.19% more ownership

Funds ownership: 7.5% → 7.69% (+0.19%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

54% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 13

Holders
45
Holders Change
+3
Holders Change %
+7.14%
% of All Funds
0.71%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
6
Reduced
13
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FTCM
First Trust Capital Management
Illinois
+$7.68M
2
WCMNY
Westchester Capital Management (New York)
New York
+$5.4M
3
Marshall Wace
Marshall Wace
United Kingdom
+$4.46M
4
Millennium Management
Millennium Management
New York
+$4.22M
5
IPCP
Iron Park Capital Partners
New York
+$2.23M

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$7.63M
2
Morgan Stanley
Morgan Stanley
New York
-$5.08M
3
Blackstone Inc
Blackstone Inc
New York
-$2.96M
4
CAC
Cowen and Company
New York
-$1.81M
5
NIP
Nicholas Investment Partners
California
-$1.73M
Name Holding Trade Value Shares
Change 		Change in
Stake
KC
26
Kingfisher Capital
North Carolina
$1.09M -$6.81K -69 -0.6%
T. Rowe Price Associates
27
T. Rowe Price Associates
Maryland
$994K – – –
SCM
28
Segantii Capital Management
Hong Kong
$988K – – –
MTCM
29
Mint Tower Capital Management
Netherlands
$987K – – –
Goldman Sachs
30
Goldman Sachs
New York
$814K – – –
DCM
31
Dupont Capital Management
Delaware
$691K – – –
SSA
32
Schonfeld Strategic Advisors
New York
$596K +$115K +1,161 +24%
RL
33
RPO LLC
Connecticut
$480K +$481K +4,871 New
CAC
34
Cowen and Company
New York
$466K -$1.81M -18,350 -80%
HSBC Holdings
35
HSBC Holdings
United Kingdom
$436K +$437K +4,426 New
BFM
36
Boothbay Fund Management
New York
$291K +$291K +2,950 New
HF
37
HRT Financial
New York
$290K -$19.3K -196 -6%
Geode Capital Management
38
Geode Capital Management
Massachusetts
$277K -$94.3K -955 -25%
RCM
39
Radcliffe Capital Management
Pennsylvania
$206K – – –
OAC
40
OMERS Administration Corp
Ontario, Canada
$168K +$168K +1,701 New
FIA
41
FNY Investment Advisers
New York
$58K -$1.52M -15,418 -96%
PCM
42
Penserra Capital Management
California
$27K +$27K +274 New
UBS Group
43
UBS Group
Switzerland
$21K +$21.2K +215 New
TRCT
44
Tower Research Capital (TRC)
New York
$7K -$99 -1 -1%
Toronto Dominion Bank
45
Toronto Dominion Bank
Ontario, Canada
$1K +$790 +8 New
Blackstone Inc
46
Blackstone Inc
New York
– -$2.96M -30,000 Closed
NIP
47
Nicholas Investment Partners
California
– -$1.73M -17,500 Closed
CL
48
CSS LLC
Illinois
– -$818K -8,295 Closed
Tudor Investment Corp
49
Tudor Investment Corp
Connecticut
– -$351K -3,559 Closed
Citadel Advisors
50
Citadel Advisors
Florida
– -$149K -1,507 Closed
1
2
3

SNTI Hedge Fund Activity: Q1 2022 in Review

45 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Senti Biosciences Holdings (SNTI) for Q1 2022, worth a combined $180M — up 2.6% from $175M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new SNTI positions and 8 closed out — a net gain of 3 holders — while 6 added to existing stakes and 13 trimmed.

The largest buyer was First Trust Capital Management, opening a new position worth an estimated $7.68M. The largest seller was JP Morgan Chase, cutting an estimated $7.63M.

  • 45 institutional investors held Senti Biosciences Holdings (SNTI) as of Q1 2022, up from 42 in Q4 2021.
  • Funds reported $180M of Senti Biosciences Holdings stock for Q1 2022, up 2.6% quarter-over-quarter.
  • 11 funds opened new Senti Biosciences Holdings positions in Q1 2022 and 8 closed out, a net change of +3 holders.
  • The largest Senti Biosciences Holdings buyer in Q1 2022 was First Trust Capital Management, an estimated $7.68M added.
  • The largest Senti Biosciences Holdings seller in Q1 2022 was JP Morgan Chase, an estimated $7.63M sold.

Based on aggregated 13F filings for Q1 2022.